Compass Therapeutics, Inc.

CMPX · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
102
SEC Filings

Business Summary

PART I . Overview We are a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Our scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. Our pipeline of novel product candidates is designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted age...

Next Earnings

Q2 FY2026 — expected 2026-08-11

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCMPXdiscussed_in_filing Cybersecurity
topic_mentionCMPXdiscussed_in_filing Trusted Computing
topic_mentionCMPXdiscussed_in_filing Blockchain & Crypto
topic_mentionCMPXdiscussed_in_filing Capital Expenditure
topic_mentionCMPXdiscussed_in_filing Regulation
topic_mentionCMPXdiscussed_in_filing Healthcare & Bio
topic_mentionCMPXdiscussed_in_filing Platform & Ecosystem
topic_mentionCMPXdiscussed_in_filing Sovereign & Government
topic_mentionCMPXdiscussed_in_filing Cybersecurity
topic_mentionCMPXdiscussed_in_filing Trusted Computing
topic_mentionCMPXdiscussed_in_filing Blockchain & Crypto
topic_mentionCMPXdiscussed_in_filing Capital Expenditure
topic_mentionCMPXdiscussed_in_filing Regulation
topic_mentionCMPXdiscussed_in_filing Healthcare & Bio
topic_mentionCMPXdiscussed_in_filing Platform & Ecosystem
topic_mentionCMPXdiscussed_in_filing Sovereign & Government
topic_mentionCMPXdiscussed_in_filing Cybersecurity
topic_mentionCMPXdiscussed_in_filing Trusted Computing
topic_mentionCMPXdiscussed_in_filing Blockchain & Crypto
topic_mentionCMPXdiscussed_in_filing Capital Expenditure

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-052025-12-310001171843-26-001337EDGAR81K words
2025-02-272024-12-310001171843-25-001106EDGAR—
2024-03-212023-12-310001171843-24-001516EDGAR—
2023-03-152022-12-310001171843-23-001691EDGAR—
2022-03-182021-12-310000950170-22-004156EDGAR—
2021-03-052020-12-310001564590-21-011110EDGAR—
2020-06-082020-03-310001213900-20-014390EDGAR—
2019-07-012019-03-310001213900-19-011850EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300001171843-25-007005EDGAR14K words
2025-08-112025-06-300001171843-25-005261EDGAR—
2025-05-082025-03-310001171843-25-002953EDGAR—
2024-11-122024-09-300001171843-24-006248EDGAR—
2024-08-122024-06-300001171843-24-004670EDGAR—
2024-05-132024-03-310001171843-24-002785EDGAR—
2023-11-092023-09-300001171843-23-006912EDGAR—
2023-08-032023-06-300001171843-23-004947EDGAR—
2023-05-042023-03-310001171843-23-002868EDGAR—
2022-11-092022-09-300001171843-22-007269EDGAR—
2022-08-012022-06-300001171843-22-005187EDGAR—
2022-05-092022-03-310000950170-22-008244EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-050001171843-26-001336EDGAR2K words
2026-01-060001171843-26-000083EDGAR—
2025-11-050001171843-25-007004EDGAR—
2025-08-130001193125-25-179958EDGAR—
2025-08-110001171843-25-005260EDGAR—
2025-06-120001171843-25-003868EDGAR—
2025-05-080001171843-25-002952EDGAR—
2025-04-010001171843-25-001900EDGAR—
2025-02-270001171843-25-001105EDGAR—
2025-01-080001171843-25-000116EDGAR—

102 total filings indexed. 72 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001738021
TickerCMPX
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 38e9dbc656f244310c2a9ddf40510f1eb811dd81220b536de2093e93d78a5b2b
parent: 33c8a7f476a25ffb305195ac355b951a6cd10963040d08d341ab0476b4fef661
content hash: 9645beae34db7f595c61298f1d50c9b212bbb5246396df1dcf5f0b504333c844
signed: 2026-04-13T04:44:23.642Z
sources: 20 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf